Clinical Trial Update: Dendritic Cell Based Therapy of Metastatic Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 dendritic cell-based therapy trial for metastatic breast cancer was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Dendritic cell-based therapy

Snippet

Sponsor: Herlev Hospital | Conditions: Metastatic Breast Cancer | Phase 1, Phase 2 | Status: TERMINATED